Pular para o conteúdo principal
Ranking Invest

RYTM - Rhythm Pharmaceuticals, Inc.

Segmento: HealthcareRhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. Rhythm Pharmaceuticals, Inc. has a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Análise Ranking Invest

Valuation estimado
-$ 663.22 Mi
Valor de Mercado
$ 7.22 Bi
Desconto (AV)-1188.2%
IVR
-0.09A companhia vale -0,09 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.11O valuation alternativo equivale a -11% do valor de mercado da companhia.
MLL
-0.11O lucro líquido dos controladores em 16 trimestres equivale a -11% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 102.98 Mi

Dívida Líquida

$ 40.49 Mi

L4T

-$ 205.35 Mi

MM4T

-86.96%

Indicadores Básicos

ROE

-199.40%

Índices de Previsibilidade

Receita Líquida

D0.09

Lucro

A0.07

Margem

C0.51

Índices de Tendência

Receita Líquida

A11.64

Lucro

F-5.94

Margem

A9.28

Índices de Endividamento

DIV/PAT

0.39

DIV/L4T

-0.20

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.